Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene editing
Biotech
Wave reports AATD win, but investors lukewarm
The biotech's stock slipped even though its RNA editing treatment restored alpha-1 antitrypsin to clinically meaningful levels.
Darren Incorvaia
Sep 3, 2025 3:00pm
NIH gene editing fixes Tay-Sachs mutation in mice
Aug 19, 2025 4:22pm
Eli Lilly pays $1B upfront to buy gene editing partner Verve
Jun 17, 2025 4:35am
Gene editing leaders call for 10-year ban on heritable edits
May 28, 2025 7:00am
CRISPR Tx, Sirius pen collab with a focus on thrombotic disease
May 20, 2025 3:59am
Boy with rare disease 'thriving' after 1st custom gene therapy
May 15, 2025 1:00pm
